<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00497211</url>
  </required_header>
  <id_info>
    <org_study_id>EC 3/39/123</org_study_id>
    <nct_id>NCT00497211</nct_id>
  </id_info>
  <brief_title>Intracoronary Infusion of BM-Derived Mononuclear Cells in Patients With Large Acute Myocardial Infarction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Large acute myocardial infarctions are the most frequent cause of subsequent systolic heart
      failure. Some evidence exists on the improvement after intracoronary administration of bone
      marrow cells in patients with a recente acute myocardial infarction. Although subgroup
      analyses suggest that patients with the largest myocardial infarctions have the largest
      increase in ejection fraction after intracoronary bone marrow administration, there is no
      published trial including only large myocardial infarctions. Therefor we sought to confirm
      the subgroup analyses by conducting a trial in only large first acute myocardial infarction
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intracoronary mononuclear cell infusion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥20 and &lt;80 years old

          -  Acute myocardial infarction &gt;2 and &lt;96 hours from start to reperfusion

          -  Cumulative ST-segment elevation &gt;6 mm on 12 lead ECG

          -  No functional myocardial impairment outside the myocardial infarction region

          -  Succesful PCI of infarct related coronary artery

          -  Left ventricular ejection fraction &lt;50% on ventriculography, echo or MRI

          -  Accepted anticonceptive use during the study for women of childbearing potential

          -  Written and signed informed consent

        Exclusion Criteria:

          -  CPR &gt; 10 minuts or persistent cardiogenic shock

          -  complete left bundle branch block without concordant ST-segment elevation

          -  Need foor cardiac surgery (valvular, coronary or other)

          -  Trombocytopenia, coagulation disorders or hematological disease

          -  History or active malignancy

          -  Life expectancy (apart from acute myocardial infarction) &lt;5 years

          -  Dialysis or severe kidney insufficiency (creatinin clearance &lt;30ml/')

          -  Severe liver insufficiency

          -  Severe respiratory disease

          -  Systemic inflammatory pathology (acute or chronic, apart from inflammation associated
             with myocardial infarction)

          -  Symptomatic cerebral or periferal vascular disease

          -  Prior myocardial infarction or prior myocardial dysfunction

          -  Prior CABG or heart valve surgery

          -  Pregnancy, pregnancy wish or lactation &lt;1 month

          -  Psychiatrical illness

          -  Physical or psychological inability to adhere to the protocol

          -  Participation in other not yet completed study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven E Haine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Antwerpen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris Vrints, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UZ Antwerpen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven E Haine, MD</last_name>
    <phone>0032.3.821.42.81</phone>
    <email>steven.haine@uza.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Myriam Michiels, Nurse</last_name>
    <phone>0032.3.821.33.04</phone>
    <email>Myriam.michiels@uza.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Antwerpen</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Johan Bosmans, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Claeys, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hielko Miljoen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2007</study_first_submitted>
  <study_first_submitted_qc>July 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2007</study_first_posted>
  <last_update_submitted>July 5, 2007</last_update_submitted>
  <last_update_submitted_qc>July 5, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2007</last_update_posted>
  <keyword>First large acute myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

